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Abstract 
 
Aging results in significant loss of mass and function of skeletal muscle, which negatively 
impacts the quality of life. In this study we investigated whether aerobic exercise training has 
the potential to alter anabolic and catabolic pathways in skeletal muscle. Five and twenty 
eight month old rats were used in the study. Aging resulted in decreased levels of 
follistatin/mTOR/Akt/Erk activation and increased myostatin/Murf1/2, proteasome subunits, 
and protein ubiquitination levels. In addition, TNF-, reactive oxygen species (ROS), p53, 
and Bax levels were increased while Bcl-2 levels were decreased in skeletal muscle of aged 
rats. Six weeks of exercise training at 60% of VO2max reversed the age-associated activation 
of catabolic and apoptotic pathways and increased anabolic signaling. The results suggest that 
the age-associated loss of muscle mass and cachexia could be due to orchestrated down-
regulation of anabolic and up-regulation of catabolic and pro-apoptotic processes. These 
metabolic changes can be attenuated by exercise training.  
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Introduction 
 
Skeletal muscle is crucial for movement and also plays an important role in sugar and fat 
metabolism, and immune response. Age-associated loss in function and mass of skeletal 
muscle is well documented (Bijlsma and others 2012; Reid and Fielding 2012). However, the 
causative mechanism(s) controlling this complex process is not well understood. Enhanced 
generation of inflammation (Degens 2010), aging-related increases in the level of reactive 
oxygen species (ROS) (Hiona and Leeuwenburgh 2008), altered metabolism (Lawler and 
Hindle 2011) , and increased rates of protein degradation (Witt and others 2008) are also on 
the list of potential causative factors of sarcopenia. Indeed, it has been reported that 
administration of exogenous tumor necrosis factor alpha (TNF-) leads to a significant 
decrease in the mass of skeletal muscle (Llovera and others 1993). This cytokine can interfere 
with the contractile properties of skeletal muscle causing decreased force generating capacity 
(Reid and others 2002). Inflammation can readily increase the concentration of ROS, which 
above certain levels jeopardizes cellular function (Ji 2007; Langen and others 2003; Radak 
and others 2005). Recently it has been reported that myostatin, which is a negative regulator 
of muscle growth and is induced in aged skeletal muscle (Bowser and others 2013; Brioche 
and others 2013), can also add to higher levels of ROS (Sriram and others 2011). Increased 
levels of myostatin can readily reduce protein synthesis (Hitachi and others 2014) and it 
appears that the rate of protein degradation is enhanced in aged skeletal muscle (Goto and 
others 2007). It has also been shown that the ubiquitin-dependent proteasome system can be 
activated with aging (Radak and others 2002), and recent information indicates that muscle 
RING finger 1/2 (Murf1/2), which is an ubiquitin ligase, could have an important role in 
aging skeletal muscle (Sacheck and others 2007). Thus, it is obvious that the mechanism(s) 
affecting muscular atrophy is very complex and extremely complicated.  
Physical exercise has been shown to retard age-associated loss of muscle mass (Dickinson and 
others 2013), and supplementation of growth hormone (Brioche and others 2013; Nass 2013).  
 
Therefore the aim of the present study was to obtain a picture of the signaling anabolic, 
catabolic and apoptotic pathways of aged skeletal muscle. The role of aerobic exercise 
training on these pathways was investigated. 
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Methods 
 
Animals and training protocol 
Twelve  young (three months old) and twelve eight month old male Wistar rats were used in 
the study and grouped into young control (YC), young exercised (YE),  old control (OC), old 
exercised (OE).  
The investigation was carried out according to the requirements of The Guiding Principles for 
Care and Use of Animals, EU, and approved by the local ethics committee. Exercised rats 
were introduced to treadmill running for three days; then for the next two weeks the running 
speed was set at 10 m/min, with a 5% incline for 30 min/day. The running speed and duration 
of the exercise were gradually increased to 60% of VO2max of the animals. As a result, by 
the final week of the six weeks training program, young animals ran at 22 m/min, on a 10% 
incline, for 60 min, whereas old animals ran at 13 m/min, and a 10% incline for 60 min.  
At the end of the study, the rats were anaesthetized with intraperitoneal injections of ketemine 
(50 mg/kg) and perfused by 4% paraformaldehyde in phosphate buffered saline (PBS, pH 
7.4). This procedure was carried out two days after the last exercise session to avoid the 
metabolic effects of the final run.  
 
Quadriceps muscle was carefully excised and homogenized in buffer containing 137 
mMNaCl, 20mM Tris-HCl pH 8.0, 2% NP 40, 10% glycerol and protease inhibitors. The 
protein content was measured by the Bradford method using BSA as a standard, and the 
samples were stored at -80 C.  
 
 
Estimation of Oxidant levels and Redox Active Iron  
Intracellular oxidant and redox-active iron levels (Kalyanaraman and others 2011)) were 
estimated using modifications of the dichlorodihydrofluoresceindiacetate (H2DCFDA) 
staining method (Radak and others 2004). In brief, the H2DCFDA (Invitrogen-Molecular 
Probes #D399) was dissolved to a concentration of 12.5 mM in ethanol and kept at -80 
O
C in 
the dark. The solution was freshly diluted with potassium phosphate buffer to 125 μM 
before use. For fluorescence reactions, 96-well, black microplates were loaded with 
potassium phosphate buffer (pH 7.4) to a final concentration of 152 µM/well. Then 8 µl 
diluted tissue homogenate and 40 µl 125 µM dye were added to achieve a final dye 
concentration of 25 μM. The change in fluorescence intensity was monitored every five 
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minutes for 30 minutes with excitation and emission wavelengths set at 485 nm and 538 nm 
(Fluoroskan Ascent FL). The fluorescence intensity unit was normalized with the protein 
content and expressed in relative unit production per minute.  
 
Western blots 
 
Ten to 50 micrograms of protein were electrophoresed on 8-12% v/v polyacrylamide SDS-
PAGE gels. Proteins were electrotransferred onto PVDF membranes. The membranes were 
subsequently blocked and after blocking, PVDF membranes were incubated at room 
temperature with antibodies (1:500 #sc-6884 Santa CruzGDF-8/11(C-20); 1:500 #sc-30194 
Santa Cruze Follistatin (H-114); 1:500 #sc-32920 Santa Cruz MuRF1(H-145); 1:500 #sc-
49457 Santa Cruz MuRF2(N-15); 1:1000 #9272s cell signaling Akt; 1:1000 #9271s cell 
signaling Phospho-Akt (Ser473); 1:500 #sc-8319 Santa Cruz mTOR (H-266); 1:1000 #5536 
cell signaling Phospho-mTOR (Ser2448); 1:1000 #9102 cell signaling p44/42 MAPK 
(Erk1/2); 1:1000 #9106 cell signaling Phospho-p44/42 MAPK (Erk1/2)(Thr202/Tyr204); 
1:500 #sc-1350 Santa Cruz TNFα(N-19); 1:500 #sc-526 Santa Cruz Bax (P-19); 1:500 #sc-
492 Santa Cruz Bcl-2 (N-19); 1:500 #sc-1311 Santa Cruz p53 (C-19); 1:1000 #2459 cell 
signaling PSMA6; 1:1000 #3936 cell signaling Ubiquitin (P4D1); 1:500 #sc-15404 Santa 
Cruz SIRT1 (H-300); 1:500 #sc-69359 Santa Cruz COX4 (D-20); 1:500 #sc-7159 Santa Cruz 
cytochrome c (H-104); 1:2000 #sc-81178 Santa Cruz ß-Actin (ACTBD11B7). After 
incubation with primary antibodies, membranes were washed in TBS-Tween-20 and 
incubated with HRP-conjugated secondary antibodies. After incubation with the secondary 
antibody, membranes were repeatedly washed. Membranes were incubated with 
chemiluminescent substrate (Thermo Scientific, SuperSignal West Pico Chemiluminescent 
Substrate #34080) and protein bands were visualized on X-ray films. The bands were 
quantified by ImageJ software, and normalized to ß-actin, which served as an internal control. 
 
Statistical analyses 
Statistical significance was assessed by Kruskal-Wallis ANOVA followed by Mann-Whitney 
U test in case of those variables where post-hoc analysis was adequate. The significance level 
was set at p < 0.05. 
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Results 
 
 
The effects of aging 
 
Aging resulted in significant decrease in the protein content of cytochrome C (Fig. 1A) and 
COX4 (Fig. 1B), indicating decreased mitochondrial content. The ROS levels were 
appraised using the H2DCFDA staining method, and age-associated increase was detected 
(Fig. 2). Myostatin, which is a negative regulator of muscle growth significantly increased 
with aging (p<0.01) (Fig. 3A). An age-associated decrease in the follistatin levels, which is 
the antagonist of myostatin, was observed in OC group compared to YC (Fig. 3B). The ratio 
of pmTOR/mTOR, pAkt/Akt, did not change significantly as a result of aging (Fig. 3C,D,). 
However the ratio of pERK/ERK increased in aged control group compared to young 
controls (Fig. 3E).  
The assessment of protein degradation was made by measuring Murf1, Murf2, proteasome 
subunit alpha (PSMA6), and protein ubiquitination. Generally, all of these markers 
increased with aging Fig. 4A-D). Degradation of proteins is associated with apoptosis and 
an increase in p53 levels was detected as a result of aging (Fig. 5A). Bax is a pro-apoptopic 
protein and an age-associated increase in this protein was found in the skeletal muscle 
(p<0.01) (Fig. 5B). TNF- is an adipokine which can relate to apoptosis and it has been 
found unaltered with aging (Fig. 5C). Bax induces apoptosis by binding the Bcl-2 family, 
which was found to be significantly lower in aged muscle than in young muscle (Fig. 5D). 
SIRT1 is anti-apoptotic protein, which levels was not altered by aging (Fig. 5E).  
 
 
The effects of exercise training 
 
Six weeks running training at the intensity of 60% of VO2max resulted in an adaptive 
response in mitochondrial enzymes with significant elevation of cytochrome C levels in both 
young and aged groups. The training program eliminated the age-associated loss of 
cytochrome C (Fig. 1A) and COX4 (Fig. 1B). Exercise training did not significantly change 
the levels of ROS. Aerobic exercise training did not change the myostatin levels (Fig. 3A), 
however eliminated the age-associated increase. In accordance with this change, the 
follistatin levels increased by training in aged animals (Fig. 3B).  
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Exercise increased the pmTOR/mTOR levels in aged groups, while no statistical alteration 
was present in young groups, and this was true for pAkt/Akt ratio (Fig. 3C,D). However, 
exercise prevented the age related increase in the ratio pERK/ERK (Fig. 3E). Exercise 
training decreased the protein levels of Murf1 aged groups compared to  aged control rats 
(Fig. 4A), while exercise  decreased the levels of Murf2 in both age groups (Fig. 4B).  
Interestingly statistical increase in PSMA6 and ubiquitination levels were found between 
young control and young exercise rats (Fig. 4. C,D), while in aged groups exercise does not 
significantly altered the levels of PSMA6 and protein ubiquitination. Exercise training did 
not result in significant alteration of p53, Bax, TNF-  and SIRT1 levels (Fig. 5. A,B,D,E), 
the only statistical difference in these apoptotic markers was that exercise decreased the 
Bcl2 levels in young group compared to young control rats (Fig. 5C).  
 
 
Discussion 
 
Age-associated loss in function and size of skeletal muscle leads to a decreased quality of life. 
The findings of the present study suggest that the loss of muscle mass is due to decreased 
activity of anabolic pathways and increased activity of catabolic pathways in skeletal muscle.  
The follistatin mediated anabolic pathway was found to be down-regulated in aged skeletal 
muscle. The IGF pathway is known to promote myogenesis (Rosen and others 1993), and 
follistatin mediated inhibition of myostatin causes enhanced expression of IGF-1(Gilson and 
others 2009) and activation of anabolic pathways, probably through an IGF-receptor (IGF-
IR). Data from the present study demonstrate that aging results in down-regulation of 
follistatin mediated pathways. This is finding is in accordance with the observation, that 
administration of follistatin results in increased muscle protein synthesis (Suryawan and 
others 2006). Aerobic exercise has been shown to elevate serum levels of follistatin (Gorgens 
and others 2013), while exercise can activate Akt and Erk pathways (Boonsong and others 
2007; Fuentes and others 2011; Pasiakos and others 2010; Williamson and others 2006), 
leading to enhanced production of follistatin (Chen and Ruiz-Echevarria 2013). In the present 
study we have observed that exercise could counter act with the effects of aging on follistatin 
levels, and this could be an important means by which regular exercise could attenuate 
sarcopenia.  
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The significant decrease in mass of skeletal muscle could be also due to the enhanced level of 
catabolic processes. Myostatin is a powerful negative regulator of muscle growth. Myostatin 
signaling results in activation of Smad2 and Smad3 and consequently the regulation of 
MyoDas well as the ubiquitin-associated degradation (Attisano and others 2001). This 
pathway is activated in aged skeletal muscle, suggesting the involvement of myostatin in age-
associated muscle loss. Indeed, blockage of myostatin also curbs the activity of catabolic 
pathways (Thomas and Mitch 2013). On the other hand, cancer-associated cachexia has been 
shown to increase myostatin and Murf2 levels in skeletal muscle (Bonetto and others 2009). 
These data suggest a functional link between myostatin and Murf(s) mediated catabolism. 
Murf1 and Murf2 are ubiquitin ligases but results from work using Murf1 transgenic mice 
suggest that Murf1 can interfere with the ROS production of mitochondria in the cardiac 
muscle (Mattox and others 2014). Similar interaction could be present in the skeletal muscle. 
Murf1/Murf2 has been implicated in the remodeling of type-II fibers in skeletal muscle 
(Moriscot and others 2010) as these fibers  lose more total area and function than  type-I 
fibers during the aging process (Deschenes 2004; Pak and Aiken 2004). The increased level of 
Murf1/Murf2, hence, can be a compensatory mechanism to try to remodel these fibers, which 
includes degradation of damaged fibers. Aging resulted in increased levels of  ROS, which are 
initiators/consequences of muscle wasting (Eley and others 2008) and closely related to the 
activation of apoptosis (Favier and others 2008). It has been reported that age-associated 
increases in p53 in skeletal muscle leads to mitochondrial release of cytochrome c 
and apoptosis (Tamilselvan and others 2007). In the present study aging resulted in increased 
levels of pro-apoptotic proteins p53 and Bax and down-regulation of anti-apoptotic Bcl-2 
protein. 
 
Exercise associated decrease in the levels of p53 and Bax in proteins could counteract the 
age-mediated pro-apoptotic pathways. SIRT1 is considered to be an anti-apoptotic protein 
(Radak and others 2013). However, an age-associated alteration of this protein was not 
observed, although exercise training increased the content of this protein in the older group. 
We have previously reported, using the same animals, that exercise increased the activity of 
SIRT1 (Koltai and others 2010). However, it is not clear if that finding affects the anti-
apoptotic role of SIRT1. In addition, it has to be mentioned that the role of sirtuins in aging 
is very complex, sirtuins belong to the vitagen family together with heat shock proteins and 
thioredoxin (Calabrese and others 2011; Calabrese and others 2010; Calabrese and others 
2012; Cornelius and others 2013). The U-shape dose response curve, which is often called 
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hormesis, is very representative to oxidants, oxidative damage and vitagens, and without 
question vitagens could play an important role in aging process (Calabrese and others 2007; 
Radak and others 2011). Nevertheless, the role of SIRT1 in age-associated loss of muscle 
mass needs further verification. 
 
In conclusion, we report that aging results in significant decreases in anabolic processes of 
skeletal muscle by activation of the follistatin pathway. This finding, together with the data 
that show enhanced activation of myostatin, Murf1/2, PMSA6, protein ubiquitinating 
pathway, and apoptosis in skeletal muscle of aged animals, suggests that the age-associated 
loss in muscle mass is a result of altered protein synthesis and degradation. Exercise training, 
can reverse the decline in anabolic processes and increases in catabolic and apoptotic 
processes, and serve as an important tool to fight sarcopenia and cachexia.  
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Figure legends 
 
Fig. 1.The levels of cytochrome C and COX 4 
Mitochondrial content was evaluated by cytochrome c and COX 4. Groups: YC, 
young control; YE, young exercised; YEI, young exercised IGF-1 treated, OC, old 
control; OE, old exercised, OEI, old exercised IGF-1 treated. Values are means ± SE 
for six animals per group. *p<0.05, **p<0.01. 
 
Fig. 2. The evaluation of ROS content 
The measurement of ROS levels was done by fluorescent detection of 
H2DCFDA.Groups: YC, young control; YE, young exercised; YEI, young exercised 
IGF-1 treated, OC, old control; OE, old exercised, OEI, old exercised IGF-1 treated. 
Values are means ± SE for six animals per group. *p<0.05, **p<0.01. 
 
Fig. 3. Anabolic factors of skeletal muscle 
Myostatin (A) and follistatin (B) levels were evaluated by Western blot. The activites 
of mTOR (C), Akt (D) ERK (E), were measured by the ratio of phosphorylated and 
total levels of mTOR, Akt and ERK. Groups: YC, young control; YE, young 
exercised; YEI, young exercised IGF-1 treated, OC, old control; OE, old exercised, 
OEI, old exercised IGF-1 treated. Values are means ± SE for six animals per group. 
*p<0.05, **p<0.01. 
 
Fig. 4. Catabolic factors of skeletal muscle 
MuRF1 (A) and MuRF2 (B) PSMA6 (C) and protein ubiquitination (D) levels were 
evaluated as markers of protein degradation. Groups: YC, young control; YE, young 
exercised; YEI, young exercised IGF-1 treated, OC, old control; OE, old exercised, 
OEI, old exercised IGF-1 treated. Values are means ± SE for six animals per group. 
*p<0.05, **p<0.01. 
 
Fig. 5.Proaptotic and anti apoptotic markers in skeletal muscle 
Pro-apoptotic factors  p53 (A), BAX (B), and TNF-a (C) and anti-apoptotic factors  
Bcl-2 (D) and SIRT1 (E) were measured by immunoblot. Groups: YC, young 
control; YE, young exercised; YEI, young exercised IGF-1 treated, OC, old control; 
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OE, old exercised, OEI, old exercised IGF-1 treated. Values are means ± SE for six 
animals per group. *p<0.05, **p<0.01. 
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